| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8531964 | Journal of the American Pharmacists Association | 2017 | 20 Pages |
Abstract
Pooled risk estimates from this meta-analysis reveal that polypharmacy is associated with increased mortality risk, using both discrete and categorical definitions. The causality of this relationship remains unclear, but it emphasizes the need for approaches to health care delivery that achieve an optimal balance of risk and benefit in medication prescribing.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Nattawut Leelakanok, Andrea L. Holcombe, Brian C. Lund, Xiaomei Gu, Marin L. Schweizer,